Cell Viability Calculators
0 calculators tagged with “Cell Viability”
All Calculators
No calculators found for this topic.
Trypan Blue Exclusion
Most common manual method. Live cells (intact membranes) exclude trypan blue → clear. Dead cells (compromised membranes) take up blue dye → blue/stained. Count with hemocytometer. Viability % = (clear cells / total cells) × 100. Limitations: subjectivity; cannot distinguish early apoptotic from live; trypan blue is mildly toxic if exposure is prolonged. Target viability for experiments: ≥ 90% (most cell biology); ≥ 95% for transfection; ≥ 85% minimum for most assays.
MTT Assay (Colorimetric Metabolic Activity)
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is reduced by mitochondrial enzymes in metabolically active cells to a purple formazan product. Absorbance measured at 570 nm. Relative viability = (A_treated/A_control) × 100%. Does not give absolute cell count; measures metabolic activity (proxies for viability). Related reagents: MTS, WST-1, resazurin (Alamar Blue) — all colorimetric metabolic activity assays.
Flow Cytometry Viability
PI (propidium iodide): penetrates compromised membranes; intercalates into DNA; fluorescent → dead cells are PI-positive. DAPI: similar principle to PI. Live/Dead fixable dyes: react with amines; dead cells stain brighter (more amine-reactive sites exposed). Annexin V/PI: Annexin V binds phosphatidylserine (flipped to outer membrane in early apoptosis, PI-negative); late apoptotic/necrotic cells are PI-positive.
Glossary
Frequently Asked Questions
Cell viability = percentage of living cells: viability % = (live cells / total cells) × 100. 'Live' is defined differently by different assays: trypan blue exclusion: live = membrane-intact (dye excluded); MTT assay: live = metabolically active (reduces tetrazolium dye); flow cytometry: live = PI-negative and FSC/SSC profile consistent with intact cells. Example: hemocytometer count shows 250 clear cells + 12 blue cells: total = 262; live = 250; viability = (250/262) × 100 = 95.4%. Viable cell density = viability% × total cell density.
Trypan blue exclusion: directly counts live and dead cells based on membrane integrity; gives absolute cell numbers; performed at a single time point; fast (< 5 min); requires hemocytometer or automated cell counter; cell count is independent of cell size or metabolism. MTT (colorimetric): measures metabolic activity of the cell population as a whole; gives relative values (treated vs. control); suitable for high-throughput (96-well plates); cannot distinguish whether reduced absorbance is due to fewer cells or less active cells; takes 2–4 hours; better for drug dose-response screening. Use trypan blue for routine culture monitoring and absolute counts; MTT for drug screening and comparative viability studies.
Annexin V/PI dual staining by flow cytometry discriminates: early apoptosis = Annexin V+/PI− (phosphatidylserine flipped to outer membrane, membrane still intact); late apoptosis = Annexin V+/PI+ (membrane integrity lost); necrosis = Annexin V−/PI+ (membrane rupture without apoptotic PS flip); live = Annexin V−/PI−. Caspase activity assays (CellEvent Caspase-3/7 green) specifically detect initiator and effector caspases — biochemical hallmarks of apoptosis. Morphology: apoptosis = cell shrinkage, nuclear condensation, membrane blebbing; necrosis = cell swelling, organelle disintegration, plasma membrane rupture. Differentiating apoptosis from necrosis matters for mechanistic understanding of cell death pathways.
Minimum acceptable viability depends on the experiment: general cell culture maintenance: ≥ 85% viability (flag for subculture if lower). Routine assays and biochemistry: ≥ 90%. Transfection/electroporation: ≥ 90–95% (stressed cells transfect poorly). Flow cytometry: ≥ 80% (dead cells cause non-specific staining and background). Cell therapy/clinical products: FDA requires ≥ 70% post-thaw for many products; ≥ 80% is preferred for infusion. Stem cell protocols: ≥ 90–95% (less robust cells). Low viability causes: delayed culture establishment; poor assay performance; non-specific drug responses; false interpretation of treatment effects. Always record and report cell viability at seeding.